WGWei Gong

Wei Gong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Wei Gong has a total of 71 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Identification of Secreted Modular Calcium-Binding Protein 1 as a Novel Endogenous Protective Molecule Against Acute Myocardial Infarction–Induced Cardiac Rupture

    by Wei Gong, Siyi Li, Zekun Zhang, Yan Yan, Hui Ai, Yu Li, Theodore A. Christopher, Bernard Lopez, Xinliang (Xin) Ma, Shaoping Nie

    BACKGROUND: Cardiac rupture is a catastrophic complication of acute myocardial infarction (AMI), with poorly understood molecular mechanisms and no available therapeutic interventions. METHODS: Plasma samples were obtained from patients with AMI and animal models, while left ventricular tissue was collected from AMI mice. An unbiased proteomics analysis identified proteins significantly altered in patients with AMI with cardiac rupture. To explore causal relationships and underlying mechanisms, we used loss- and gain-of-function animal models. RESULTS: Proteomics analysis revealed that 9 proteins were significantly upregulated and 24 proteins were significantly downregulated in patients with AMI with cardiac rupture compared with those without. Among these, SMOC-1 (secreted modular calcium-binding protein 1) was the most significantly upregulated protein. Validation in extended patient cohorts and animal models confirmed these findings. A time-course study revealed that SMOC-1 expression was transiently elevated, peaking 1 day after AMI and returning to baseline within a week. Immunological and cell-specific analyses identified cardiomyocytes as the predominant source of SMOC-1 in response to AMI. Surprisingly, cardiomyocyte-specific SMOC-1 knockout doubled the incidence of post-AMI cardiac rupture and reduced survival, while adeno-associated virus serotype 9–mediated SMOC-1 overexpression significantly decreased cardiac rupture rates. Mechanistic studies revealed that cardiomyocyte-derived SMOC-1 supports fibrosis by activating fibroblasts, enhancing collagen synthesis, and promoting collagen maturation, all of which are critical for the formation of reparative scars. SMOC-1 was shown to bind TGF-βR1 (transforming growth factor β receptor 1) in fibroblasts, recruiting EPRS (glutamyl-prolyl-tRNA synthetase) to form a signaling complex that activates the Smad pathway. Inhibiting EPRS abolished the profibrotic effects of SMOC-1. CONCLUSIONS: Our study provides the first evidence that the transient upregulation and secretion of cardiomyocyte-derived SMOC-1 constitute an intrinsic profibrotic and antirupture response to severe ischemic injury. However, this natural protective mechanism is insufficient to fully prevent cardiac rupture, highlighting the potential of enhancing the SMOC-1 pathway as a promising therapeutic strategy to mitigate cardiac rupture and reduce AMI-associated mortality.


  • Open Access

    Circular RNAs: key orchestrators of pathological remodeling in heart failure

    by Xin Wang, Wenrui Sun, Shaoping Nie, Wei Gong

    Heart failure (HF) is a complex syndrome driven by structural remodeling, fibrosis, metabolic imbalance, and oxidative stress. Circular RNAs (circRNAs) have emerged as pivotal regulators in HF, distinguished by their covalently closed structure, stability, and tissue specificity. While they modulate myocardial hypertrophy, fibrosis, and metabolic pathways through mechanisms including microRNA (miRNA) sponging, protein interactions, and transcriptional regulation, emerging evidence highlights their critical role in regulating intracellular Ca2+ homeostasis and excitation-contraction (E-C) coupling. By modulating key calcium-handling proteins, circRNAs directly influence cardiomyocyte contractility and arrhythmia susceptibility, linking RNA networks to dynamic cardiac function beyond structural remodeling. Beyond their mechanistic roles, the inherent stability and tissue-specificity of circRNAs position them as highly promising biomarkers for early diagnosis, risk stratification, and therapeutic monitoring. Furthermore, their therapeutic potential is rapidly unfolding; strategies involving extracellular vesicle delivery or targeted silencing offer viable cell-free approaches to inhibit fibrosis and restore cardiac function. This review systematically dissects the multifaceted roles of circRNAs in HF, from their fundamental impact on pathophysiology to their translational journey as biomarkers and therapeutic targets. We also explore current challenges and future directions, providing a comprehensive theoretical framework for the development of circRNA-based precision interventions for heart failure.

  • Open Access

    Longitudinal changes of obstructive sleep apnea and its impact on cardiovascular outcomes: Results from the Sleep Heart Health Study

    by Wenlong Zhao, Jiaqi Du, Yixiang Liu, Yun Zhou, Zekun Zhang, Siyi Li, Yan Yan, Hui Ai, Shaoping Nie, Wei Gong

    Obstructive sleep apnoea (OSA), defined by recurrent periods of upper airway obstruction and intermittent hypoxaemia, represents an important global health issue. It is estimated that nearly 400 mi...


  • Obstructive sleep apnea increases recurrent cardiovascular event risk in younger but not older patients with acute coronary syndrome: a prospective cohort study

    by Wei Gong, Xiuhuan Chen, Wenlong Zhao, Jiaqi Du, Zekun Zhang, Jingyao Fan, Xiao Wang, Yan Yan, Hui Ai, Siyi Li, et al.


  • Open Access

    An Integrated Platelet Index Derived From PCA Is Associated With Long-Term Atherothrombotic Risk in Acute Coronary Syndrome

    by Yuefeng Wang, Jiayi Sun, Zekun Zhang, Ruiyue Yang, Jun Dong, Yuxuan Li, Xingyun Jiao, Yixiang Liu, Xingyu Chen, Wei Gong, et al.

    Background: Platelet morphological indices, such as mean platelet volume and distribution width, reflect platelet turnover and thrombo-inflammatory activity relevant to acute coronary syndrome (ACS), but their individual prognostic value remains inconsistent. This study aimed to derive an Integrated Platelet Index (IPI) using principal component analysis (PCA) to capture a multidimensional platelet morphological phenotype influenced by cardiometabolic and inflammatory stress and to examine its association with long-term major adverse cardiovascular and cerebrovascular events (MACCE) in ACS. Methods: This prospective observational study included 1,467 ACS patients from the Beijing Hospital Atherosclerosis Study. Five routinely measured platelet indices—platelet count, mean platelet volume, platelet distribution width, plateletcrit, and platelet large-cell ratio—were integrated via PCA to construct the IPI. The primary endpoint was MACCE. Cox models, restricted cubic splines, Kaplan–Meier curves, and prespecified subgroup analyses assessed the prognostic relevance of the IPI and its consistency across metabolic and clinical strata. Results: Over a median follow-up of 55.0 months, 141 patients (9.6%) experienced MACCE. Lower IPI values were associated with higher risk. Each unit increase in IPI was independently associated with a 27% lower MACCE risk after full adjustment (HR 0.73; 95% CI: 0.59–0.90). A significant L-shaped nonlinear relationship was observed, with steep risk reduction at lower IPI values. Event-free survival increased progressively across IPI tertiles. Associations remained consistent across cardiometabolic subgroups, with no significant interactions. Conclusions: The PCA-derived IPI represents an integrated platelet morphological phenotype associated with long-term atherothrombotic risk in ACS. Its nonlinear behavior and robust performance across metabolic backgrounds support its potential as an accessible, phenotype-based marker for refining secondary prevention risk stratification. What Are the Clinical Implications?: Platelet morphology and turnover are influenced by cardiometabolic and inflammatory stress, yet routine platelet indices are rarely incorporated into ACS risk assessment because each parameter reflects only a single dimension of platelet biology. By integrating five commonly available platelet indices into a single PCA-derived morphological phenotype, the Integrated Platelet Index (IPI) provides a multidimensional representation of platelet alterations relevant to atherothrombotic risk. In this study, lower IPI values consistently identified patients at higher long-term risk of MACCE, and the L-shaped nonlinear association suggests that relatively small reductions in this phenotype may reflect disproportionately adverse platelet remodeling. Because the IPI relies solely on automated complete blood count parameters, it is low-cost, universally available, and feasible for implementation in secondary prevention pathways, including in resource-limited settings. Clinically, the IPI may improve risk stratification in ACS by capturing thrombo-inflammatory and metabolic influences not detected by traditional predictors. Its stability across cardiometabolic subgroups supports broad applicability. Future studies should determine whether serial IPI monitoring can identify patients with persistent thrombotic risk and whether incorporating the IPI into validated ACS risk models enhances individualized management. Highlights: We derived an Integrated Platelet Index (IPI) representing a PCA-based morphological phenotype from five routine platelet indices. Lower IPI values identified patients with heightened long-term atherothrombotic risk after acute coronary syndrome. The IPI captures multidimensional platelet alterations shaped by thrombo-inflammatory and cardiometabolic stress. The association between IPI and adverse outcomes remained consistent across major cardiometabolic subgroups. The IPI provides an accessible, low-cost phenotype with potential utility for risk stratification in secondary prevention.

  • Open Access

    Association Between the Malnutrition Status and Adverse Cardiovascular Outcomes in Patients With Obstructive Sleep Apnea and Acute Coronary Syndrome

    by Yixiang Liu, Zekun Zhang, Wenlong Zhao, Yun Zhou, Siyi Li, Yan Yan, Hui Ai, Jingyao Fan, Wei Gong, Shaoping Nie

    Background: Malnutrition is a critical modifiable risk factor in acute coronary syndrome (ACS). Obstructive sleep apnea (OSA), prevalent in ACS, is associated with adverse outcomes and may also affect nutritional status. This study aims to elucidate the relationship between malnutrition and long‐term cardiovascular outcomes in patients with ACS with or without OSA. Methods: This is a subanalysis of the OSA‐ACS project, which consecutively enrolled patients with ACS who underwent portable sleep monitoring from June 2015 to January 2020. OSA was defined as an apnea hypopnea index ≥15 events/hour. Nutritional status was assessed using the Controlling Nutritional Status score, the Nutritional Risk Index, and the Naples Prognostic Score. The relationships between malnutrition and major adverse cardiovascular and cerebrovascular events were analyzed. Results: Among 1756 patients enrolled, 931 (53.0%) had OSA, and the prevalence of malnutrition varied by assessment index: 47.4% (Controlling Nutritional Status score), 23.0% (Nutritional Risk Index), and 87.8% (Naples Prognostic Score). During 2.9 (1.5–3.5) years of follow‐up, malnutrition was independently associated with the risk of major adverse cardiovascular and cerebrovascular events in patients with OSA (adjusted hazard ratios [aHRs] for moderate‐to‐severe malnutrition, 2.707 [95% CI, 1.128–6.494] for Controlling Nutritional Status score, 1.647 [95% CI, 1.073–2.528] for Nutritional Risk Index, and 1.962 [95% CI, 1.069–3.601] for Naples Prognostic Score) but not in those without OSA. A linear dose–response relationship between the severity of malnutrition and the risk of major adverse cardiovascular and cerebrovascular events was found in patients with OSA. Conclusions: For patients with ACS, malnutrition is independently associated with the risk of cardiovascular events, particularly those with coexisting OSA. Proactive nutritional screening may help identify this high‐risk subgroup.


  • Open Access

    Oxidative balance score and mortality: mediating role of insulin resistance across age strata in the NHANES cohort

    by Lin Zhang, Heming Zhang, Hongxia Xiang, Jiachen Zhang, Wei Gong, Junjie Xv, Xue Yu

    Background: This study examined the association between oxidative balance score (OBS), a composite measure of oxidative/antioxidative factors, and mortality, while investigating insulin resistance (IR) indices as potential mediators using a nationally representative cohort.Methods: A cohort of 11,849 U. S. adults from NHANES (2007–2018) was analyzed. OBS integrated 16 dietary and 4 lifestyle components. Mortality risks (all-cause, cardiovascular, cancer) were assessed via weighted Cox models. Mediation analysis evaluated the indirect effects of five IR indices (TyG index, TG/HDL-C, HOMA-IR, eGDR, VAI) on OBS-mortality associations, with statistical validation of mediation effects. Analyses were stratified by age (<65 vs. ≥65 years) and adjusted for sociodemographic, behavioral, and clinical covariates.Results: Higher OBS reduced risks of all-cause (HR = 0.652, 95% CI: 0.525–0.81) and cardiovascular mortality (HR = 0.605, 95% CI: 0.408–0.898), but not cancer mortality. Innovatively, eGDR mediated 17% of OBS’s protective effect on all-cause mortality in adults <65 years, while TyG index and HOMA-IR showed weaker mediation. No IR mediation occurred in older adults (≥65 years).Conclusion: Higher OBS levels were inversely associated with all-cause and cardiovascular mortality, partially mediated by insulin resistance pathways. These findings highlight OBS as a potential prognostic indicator for mortality risk.


  • Open Access

    Prognostic Value of the Systemic Inflammatory Response Index in Patients with Acute Coronary Syndrome and Obstructive Sleep Apnea

    by Qian He, Yun Zhou, Xueying Tong, Lei Zhen, Shutian Shi, Wei Gong, Shaoping Nie

    Purpose: This study aimed to investigate the effects of the systemic inflammatory response index (SIRI) on the long-term prognosis of patients with acute coronary syndrome (ACS) and obstructive sleep apnea (OSA). Patients and Methods: This prospective cohort study enrolled patients with ACS and OSA at the Beijing Anzhen Hospital between June 2015 and January 2020. The SIRI was calculated at admission for all patients. Patients with SIRI ≥ 1.16 × 109/L were classified into the high SIRI group based on the optimal cutoff value for predicting major adverse cardiovascular and cerebrovascular events (MACCE) determined by the receiver operating characteristic (ROC) curve of our cohort study. The other patients were categorized into the low SIRI group. The primary endpoint was a composite of MACCE, including cardiovascular death, recurrent myocardial infarction (MI), stroke, and ischemia-driven revascularization. Results: A total of 1011 patients with ACS and OSA were enrolled, 435 of whom (43%) were in the high SIRI group. Over a median follow-up of 2.8 (1.4– 3.6) years, 179 patients experienced MACCE. Kaplan–Meier survival analysis showed a higher cumulative incidence of MACCE in the high-SIRI group (log-rank P < 0.001). A restricted cubic spline analysis also showed a monotonic increase with a greater SIRI value for MACCE (P = 0.011). After adjusting for clinically relevant confounders, a high SIRI was independently associated with elevated MACCE risk (adjusted HR = 1.44, 95% CI 1.02– 2.05, P = 0.039). Conclusion: A high SIRI was associated with poorer clinical outcomes during long-term follow-up in patients with ACS and OSA.


  • Open Access

    Association of Weight Change Across Adulthood with Obstructive Sleep Apnea: The Multi-Ethnic Study of Atherosclerosis

    by Jiaqi Du, Wenlong Zhao, Yixiang Liu, Siyi Li, Zekun Zhang, Yun Zhou, Wenrui Sun, Hui Ai, Shaoping Nie, Wei Gong

    Purpose: The association between weight change across adulthood and obstructive sleep apnea (OSA) is unclear. This study aimed to evaluate the effect of weight change across adulthood on OSA and subsequent mortality. Methods: This study included 2019 participants of the Multi-Ethnic Study of Atherosclerosis (MESA). Weight at ages 20 and 40 was recalled at Exam 1, and height and weight were measured in Exam 5 and used to calculate current body mass index (BMI). Home-based polysomnography was conducted for each enrolled participants in the MESA Sleep Study immediately following Exam 5. The relationship between changes in BMI across adulthood and the risk of OSA was investigated using logistic regression and restricted cubic splines. In addition, the association between BMI change and all-cause mortality was examined using Cox regression. Results: Of 2019 participants (median age: 67 years; 930 [46.1%] men), 970 (48.0%) had OSA. Compared to the non-OSA group, participants in the OSA group were older, more often male, and had greater weight changes across adulthood. Logistic regression showed that increased BMI across adulthood was an independent risk factor for OSA. Further studies showed that both mild (0– 10%) and significant (> 10%) increases in BMI between the ages of 20 and 40 were associated with a higher risk of OSA, and this finding remained after adjustment for current BMI. Subgroup analyses showed consistent results for participants with current BMI < 30 or ≥ 30. In addition, weight gain from age 20 to 40 was also associated with an increased mortality risk after OSA diagnosis. Conclusion: Weight gain in early adulthood was associated with a higher risk of OSA and subsequent mortality, regardless of weight status in later life. Therefore, maintaining a normal body weight in early adulthood should be actively promoted to prevent OSA and improve prognosis.


  • Adverse effect of beta-blockers in non-ST elevation acute coronary syndrome patients with obstructive sleep apnea

    by Zekun Zhang, Siyi Li, Ge Wang, Yun Zhou, Yan Yan, Jingyao Fan, Hui Ai, Wei Gong, Shaoping Nie